相关实验视频

Updated: Jun 22, 2025

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

质母细胞瘤疫苗作为有前途的免疫疗法:挑战和当前状态

Asmae Squalli Houssaini¹, Salma Lamrabet¹, Jean Paul Nshizirungu²

¹Laboratory of Biomedical and Translational Research, Faculty of Medicine, Pharmacy and Dental Medicine of Fez, Sidi Mohamed Ben Abdellah University, Fez 30070, Morocco.

|June 27, 2024

概括

质母细胞瘤免疫疗法显示出希望,但面临挑战. 本综述探讨了障碍,并确定了像异酸脱酶这样的生物标志物,以改进质母细胞瘤治疗策略.

科学领域:

神经瘤学神经瘤学
免疫学免疫学免疫学
癌症治疗癌症治疗

背景情况:

质母细胞瘤 (GBM) 是一种具有侵略性的脑瘤,尽管使用标准治疗方法,预后不佳.
目前的研究重点是免疫疗法,包括疫苗,CAR-T细胞,检查点抑制剂和菌性病毒疗法,显示出有前途的临床试验结果.

研究的目的:

审查目前针对质母细胞瘤的免疫治疗方法.
探索影响免疫疗法疗效和质母细胞瘤耐药性的障碍.
确定关键的生物标志物,并提出克服治疗挑战的解决方案.

主要方法:

关于质母细胞瘤免疫疗法的综合文献综述.
分析临床试验数据和生物标志物研究.
识别挑战和提出解决方案,以提高治疗反应.

主要成果:

免疫疗法组合在质母细胞瘤临床试验中显示出有希望的结果.
关键生物标志物,如异酸脱酶,表皮生长因子受体和端粒酶逆转录酶被确定为潜在的目标.
详细介绍了免疫疗法有效性和质母细胞瘤耐药性的障碍.

结论:

尽管面临挑战,免疫疗法为质母细胞瘤治疗提供了一个有前途的途径.
解决已识别的障碍和利用生物标志物对于改善患者治疗结果至关重要.
需要进一步的研究和临床试验优化,以克服质母细胞瘤对免疫疗法的耐药性.

关键词:

欧洲农业基金会 (EGFR) 是一个基金.IDH IDH 是一个字母.这就是为什么 TERTTT.质母细胞瘤是一种质母细胞瘤.免疫疗法免疫疗法疫苗疫苗疫苗疫苗

更多相关视频

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.